Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 14,510 | -147,660 | -112,080 | -74,660 | -39,560 |
| Other Operating Activity | 13,390 | 270,730 | 191,940 | 110,030 | 46,220 |
| Operating Cash Flow | $27,900 | $123,070 | $79,860 | $35,370 | $6,660 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -210,440 | -172,690 | 37,850 | 33,210 | -17,340 |
| Investing Cash Flow | $-210,440 | $-172,690 | $37,850 | $33,210 | $-17,340 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -1,880 | 518,010 | 27,510 | 21,540 | 7,370 |
| Financing Cash Flow | $-1,880 | $518,010 | $27,510 | $21,540 | $7,370 |
| Exchange Rate Effect | -130 | -9,070 | -1,010 | -5,860 | -1,390 |
| Beginning Cash Position | 878,210 | 418,890 | 418,890 | 418,890 | 418,890 |
| End Cash Position | 693,650 | 878,210 | 563,110 | 503,160 | 414,190 |
| Net Cash Flow | $-184,550 | $459,310 | $144,210 | $84,260 | $-4,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 27,900 | 123,070 | 79,860 | 35,370 | 6,660 |
| Free Cash Flow | 27,900 | 123,070 | 79,860 | 35,370 | 6,660 |